---
figid: PMC2901655__zcm9990923240001
figlink: /pmc/articles/PMC2901655/figure/f1/
number: F1
caption: 'Intracellular signal transduction pathways that have been proposed to be
  involved in macrolide immunomodulation. There are three major pathways that are
  influenced by macrolides. Receptor tyrosine kinases (RTKs) are receptors for many
  polypeptide growth factors and cytokines. RTKs such as epidermal growth factor receptor
  (EGFR) stimulate MEKK, and this activates the MAPK cascade. MAPK phosphorylates
  and activates transcription factors inducing proinflammatory genes (). Macrolides
  inhibit MAPK activation, in particular, ERK1/2 activation. TLRs recognize bacterial
  molecules. For example, in response to LPS stimulation, TLR4 and adaptor molecules
  (not shown) activate the IRAK family and TAK1. TAK1 then stimulates two distinct
  pathways, the IKK complex and the MAPK pathway. The latter leads to the induction
  of AP-1, while the former activates NF-κB through the degradation of IκB proteins
  and the subsequent translocation of NF-κB (). G-protein-coupled receptor (GPCR)-
  or RTK-mediated activation of phospholipase C (PLC) produces inositol triphosphate
  (IP3). IP3 is a ligand for the intracellular IP3R channel of the endoplasmic reticulum''s
  internal Ca2+ stores. Activation of PLC also leads to the production of diacylglycerol
  (DAG), which in turn activates protein kinase C (PKC). PKC and Ca2+/calmodulin signaling
  are then activated (). Macrolides inhibit intracellular Ca2+ increase. Abbreviations:
  AP-1, activator protein 1; CaMK, calmodulin kinase; DAG, diacylglycerol; EGFR, epidermal
  growth factor receptor; ER, endoplasmic reticulum; ERK, extracellular signal-regulated
  kinase; GFR, cytokine receptor/growth factor receptor; GPCR, G-protein-coupled receptor;
  IKK, IκB kinase; IP3R, inositol triphosphate receptor; IRAK, IL-1 receptor-associated
  kinase; MEK, MAPK/ERK kinase; PKC, protein kinase C; TAK1, transforming growth factor-activated
  protein kinase 1; TLR, Toll-like receptor. Blue arrows, major pathways influenced
  by macrolides; dashed arrows, subpathways or cross-talk pathways; red lines with
  “ML,” inhibition by macrolides; white bent arrow, cell response.'
pmcid: PMC2901655
papertitle: Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory
  Medications.
reftext: Soichiro Kanoh, et al. Clin Microbiol Rev. 2010 Jul;23(3):590-615.
pmc_ranked_result_index: '169802'
pathway_score: 0.9721574
filename: zcm9990923240001.jpg
figtitle: Intracellular signal transduction pathways that have been proposed to be
  involved in macrolide immunomodulation
year: '2010'
organisms:
- Homo sapiens
ndex: 95cfefad-dec4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2901655__zcm9990923240001.html
  '@type': Dataset
  description: 'Intracellular signal transduction pathways that have been proposed
    to be involved in macrolide immunomodulation. There are three major pathways that
    are influenced by macrolides. Receptor tyrosine kinases (RTKs) are receptors for
    many polypeptide growth factors and cytokines. RTKs such as epidermal growth factor
    receptor (EGFR) stimulate MEKK, and this activates the MAPK cascade. MAPK phosphorylates
    and activates transcription factors inducing proinflammatory genes (). Macrolides
    inhibit MAPK activation, in particular, ERK1/2 activation. TLRs recognize bacterial
    molecules. For example, in response to LPS stimulation, TLR4 and adaptor molecules
    (not shown) activate the IRAK family and TAK1. TAK1 then stimulates two distinct
    pathways, the IKK complex and the MAPK pathway. The latter leads to the induction
    of AP-1, while the former activates NF-κB through the degradation of IκB proteins
    and the subsequent translocation of NF-κB (). G-protein-coupled receptor (GPCR)-
    or RTK-mediated activation of phospholipase C (PLC) produces inositol triphosphate
    (IP3). IP3 is a ligand for the intracellular IP3R channel of the endoplasmic reticulum''s
    internal Ca2+ stores. Activation of PLC also leads to the production of diacylglycerol
    (DAG), which in turn activates protein kinase C (PKC). PKC and Ca2+/calmodulin
    signaling are then activated (). Macrolides inhibit intracellular Ca2+ increase.
    Abbreviations: AP-1, activator protein 1; CaMK, calmodulin kinase; DAG, diacylglycerol;
    EGFR, epidermal growth factor receptor; ER, endoplasmic reticulum; ERK, extracellular
    signal-regulated kinase; GFR, cytokine receptor/growth factor receptor; GPCR,
    G-protein-coupled receptor; IKK, IκB kinase; IP3R, inositol triphosphate receptor;
    IRAK, IL-1 receptor-associated kinase; MEK, MAPK/ERK kinase; PKC, protein kinase
    C; TAK1, transforming growth factor-activated protein kinase 1; TLR, Toll-like
    receptor. Blue arrows, major pathways influenced by macrolides; dashed arrows,
    subpathways or cross-talk pathways; red lines with “ML,” inhibition by macrolides;
    white bent arrow, cell response.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JUND
  - FOSL2
  - JUNB
  - MAPK9
  - JUN
  - CHUK
  - IRAK1
  - TLR9
  - FOSB
  - MAPK8
  - PLCB2
  - PRKCH
  - NMUR1
  - MAPK3
  - IKBKB
  - IKBKG
  - TLR10
  - PRKCE
  - PRKCG
  - RELA
  - RELB
  - FOS
  - PRKCQ
  - PRKCZ
  - PLCB1
  - FOSL1
  - MAPK1
  - NR2C2
  - TLR4
  - TLR5
  - MAP3K1
  - NFKB2
  - PRKCD
  - REL
  - TLR6
  - TLR7
  - TLR8
  - MAPK10
  - IRF6
  - PLCB3
  - PLCG1
  - PLCG2
  - MAP2K1
  - MAPK13
  - PRKCB
  - MAPK11
  - TLR3
  - PRKCA
  - PRKCI
  - PLCB4
  - TLR2
  - PRKD3
  - MAP2K2
  - NFKB1
  - MAPK12
  - MAPK14
  - TLR1
  - Cancer
genes:
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: JNK/SAPK
  symbol: SAPK
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IRAK
  symbol: IRAK
  source: hgnc_alias_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: JNK/SAPK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK/SAPK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PLCB
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PLCB
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: MEKK
  symbol: MEKK
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K1
  entrez: '4214'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: JNK/SAPK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: LPs,
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: PLCB
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PLCB
  symbol: PLCB
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2901655__F1
redirect_from: /figures/PMC2901655__F1
figtype: Figure
---
